Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Allergy|June 29, 2017
Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity studyC-Y Lin, C-W Wang, C-Y R Hui, et al.
Clinical Pharmacology and Therapeutics|May 3, 2007
Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in womenX Fan, Y Wang, K Sun, et al.
ESMO Open|March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trialS Senan, M Özgüroğlu, D Daniel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trialH M Dhillon, M L Bell, H P van der Ploeg, et al.
Oncogene|April 19, 2011
C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancerY Shi, J Chen, Z Li, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancerE H Tan, A Szczesna, M Krzakowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522L Pusztai, C Denkert, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factorsD Goldstein, M L Bell, P Butow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2017
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trialR Hui, E B Garon, J W Goldman, et al.
Pageof 8